Author:
Bogaerts Jan,Sydes Matthew R.,Keat Nicola,McConnell Andrea,Benson Al,Ho Alan,Roth Arnaud,Fortpied Catherine,Eng Cathy,Peckitt Clare,Coens Corneel,Pettaway Curtis,Arnold Dirk,Hall Emma,Marshall Ernie,Sclafani Francesco,Hatcher Helen,Earl Helena,Ray-Coquard Isabelle,Paul James,Blay Jean-Yves,Whelan Jeremy,Panageas Kathy,Wheatley Keith,Harrington Kevin,Licitra Lisa,Billingham Lucinda,Hensley Martee,McCabe Martin,Patel Poulam M.,Carvajal Richard,Wilson Richard,Glynne-Jones Rob,McWilliams Rob,Leyvraz Serge,Rao Sheela,Nicholson Steve,Filiaci Virginia,Negrouk Anastassia,Lacombe Denis,Dupont Elisabeth,Pauporté Iris,Welch John J.,Law Kate,Trimble Ted,Seymour Matthew
Reference41 articles.
1. Rare cancers are not so rare: the rare cancer burden in Europe;Gatta;Eur J Cancer,2011
2. National Cancer Institute. Surveillance, epidemiology, and end results (SEER) program stat fact sheets: anal cancer, [accessed 03.09.14].
3. Cancer Research UK. Anal cancer incidence statistics. Cancer Research UK, ; 2014 [accessed 03.09.14].
4. Randomized phase II clinical trials;Simon;Cancer Treat Rep,1985
5. Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options;Jaspers;J Clin Oncol,2011